Pellicer, Adelina <br/><br/>
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants.  [electronic resource] 

 -  Neonatology  2013 
 - 171-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1661-7819 
<br/><br/><label>Standard No.: </label>10.1159/000351346  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Algorithms<br/>Brain--physiology<br/>Clinical Trials, Phase II as Topic--methods<br/>Humans<br/>Infant, Extremely Premature--physiology<br/>Infant, Newborn<br/>Oximetry--methods<br/>Oxygen--administration & dosage<br/>Practice Guidelines as Topic<br/>Randomized Controlled Trials as Topic--methods<br/>Spectroscopy, Near-Infrared--standards